Efficacy and safety of dupilumab in adolescent patients with moderate-to-severe atopic dermatitis

被引：0
|
作者：
Cork, M. J. [1 ]
Eichenfield, L. F. [2 ,3 ]
Blauvelt, A. [4 ]
Rosmarin, D. [5 ]
Hussain, I. [6 ]
Davis, J. D. [7 ]
Li, M. [8 ]
Zhang, Q. [7 ]
Gadkari, A. [7 ]
Eckert, L. [9 ]
Kamal, M. A. [7 ]
Bansal, A. [7 ]
机构：
[1] Univ Sheffield, Sheffield, S Yorkshire, England
[2] Rady Childrens Hosp, San Diego, CA USA
[3] Univ Calif San Diego, San Diego, CA 92103 USA
[4] Oregon Med Res Ctr, Portland, OR USA
[5] Tufts Med Ctr, Boston, MA USA
[6] Vital Prospects Clin Res Inst, Tulsa, OK USA
[7] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA
[8] Sanofi, Bridgewater, NJ USA
[9] Sanofi, Chilly Mazarin, France
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2019年 / 139卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
605
引用
收藏
页码：S104 / S104
页数：1
相关论文
共 50 条
  • [41] DUPILUMAB DEMONSTRATES CONSISTENT EFFICACY ACROSS RACIAL SUBGROUPS IN PEDIATRIC PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS
    Alexis, Andrew
    Desai, Seemal R.
    Rice, Zakiya
    Heath, Candrice
    Zhang, Haixin
    Khokhar, Faisal A.
    Marco, Ainara Rodriguez
    Shah, Parul
    ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 44 - 44
  • [42] SAFETY AND EFFICACY OF DUPILUMAB IN ADULT PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: AN ANALYSIS OF UP TO 100 WEEKS (LIBERTY AD OLE)
    Roh, Joo Young
    Park, Chun Wook
    Kim, Kyu Han
    Lee, Joo Hee
    Sun, Xian
    Rossi, Ana B.
    Shumel, Brad
    ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 53 - 53
  • [43] Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitis
    Khattri, Saakshi
    Brunner, Patrick M.
    Garcet, Sandra
    Finney, Robert
    Cohen, Steven R.
    Oliva, Margeaux
    Dutt, Riana
    Fuentes-Duculan, Judilyn
    Zheng, Xiuzhong
    Li, Xuan
    Bonifacio, Kathleen M.
    Kunjravia, Norma
    Coats, Israel
    Cueto, Inna
    Gilleaudeau, Patricia
    Sullivan-Whalen, Mary
    Suarez-Farinas, Mayte
    Krueger, James G.
    Guttman-Yassky, Emma
    EXPERIMENTAL DERMATOLOGY, 2017, 26 (01) : 28 - 35
  • [44] Efficacy of rocatinlimab for moderate-to-severe atopic dermatitis
    Devjani, Shivali
    Engel, Priya, V
    Javadi, Sogol S.
    Smith, Brandon
    Wu, Jashin J.
    LANCET, 2023, 402 (10415): : 1833 - 1834
  • [45] Evaluating the safety and efficacy of baricitinib for the treatment of moderate-to-severe atopic dermatitis
    Bridgeman, Sarah G.
    Martino, Anna K.
    Strowd, Lindsay C.
    EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (18) : 2153 - 2159
  • [46] Safety and Efficacy of Tralokinumab in Older Adults With Moderate-to-Severe Atopic Dermatitis
    Merola, Joseph F.
    Butler, Daniel C.
    Mark, Thomas
    Schneider, Shannon
    Kim, Yestle
    Abuabara, Katrina
    JAMA DERMATOLOGY, 2023, 159 (10) : 1119 - 1123
  • [47] Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitis
    Khattri, S.
    Brunner, P. M.
    Garcet, S.
    Finney, R.
    Cohen, S. R.
    Oliva, M.
    Dutt, R.
    Fuentes-Duculan, J.
    Zheng, X.
    Li, X.
    Bonifacio, K. M.
    Kunjravia, N.
    Coats, I.
    Cueto, I.
    Gilleaudeau, P.
    Sullivan-Whalen, M.
    Suarez-Farinas, M.
    Krueger, J. G.
    Guttman-Yassky, E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (05) : S41 - S41
  • [48] Efficacy and safety of 611 for the treatment of moderate-to-severe atopic dermatitis in adults
    Zhang, Jianzhong
    Zhao, Yan
    Zhou, Qinghong
    Xu, Yuyu
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 : I54 - I55
  • [49] Efficacy and safety of lebrikizumab is maintained to two years in patients with moderate-to-severe atopic dermatitis
    Guttman-Yassky, Emma
    Weidinger, Stephan
    Simpson, Eric
    Gooderham, Melinda
    Irvine, Alan
    Spelman, Lynda
    Silverberg, Jonathan
    Elmaraghy, Hany
    DeLuca-Carter, Louise
    Piruzeli, Maria Lucia Buziqui
    Hu, Chaoran
    Yang, Fan Emily
    Pierce, Evangeline
    Bardolet, Laia
    Thaci, Diamant
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 : II3 - II4
  • [50] Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis A Randomized Clinical Trial
    Silverberg, Jonathan, I
    Simpson, Eric L.
    Thyssen, Jacob P.
    Gooderham, Melinda
    Chan, Gary
    Feeney, Claire
    Biswas, Pinaki
    Valdez, Hernan
    DiBonaventura, Marco
    Nduaka, Chudy
    Rojo, Ricardo
    JAMA DERMATOLOGY, 2020, 156 (08) : 863 - 873
12345